Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
Torregrosa C, Pernot S, Vaflard P, Perret A, Tournigand C, Randrian V, Doat S, Neuzillet C, Moulin V, Stouvenot M, Roth G, Darbas T, Auberger B, Godet T, Jaffrelot M, Lambert A, Dubreuil O, Gluszak C, Bernard-Tessier A, Turpin A, Palmieri LJ, Bouche O, Goujon G, Lecomte T, Sefrioui D, Locher C, Grados L, Gignoux P, Trager S, Nassif E, Saint A, Hammel P, Lecaille C, Bureau M, Perrier M, Botsen D, Bourgeois V, Taieb J, Auclin E. Torregrosa C, et al. Among authors: perret a. Int J Cancer. 2022 Dec 1;151(11):1978-1988. doi: 10.1002/ijc.34166. Epub 2022 Jul 14. Int J Cancer. 2022. PMID: 35833561
Is intra-arterial hepatic chemotherapy painful?
Kerbage F, Grinda T, Smolenschi C, Boige V, Malka D, Burtin P, Perret A, Abdullah J, Berthou H, Hollebecque A, Ducreux M. Kerbage F, et al. Among authors: perret a. Support Care Cancer. 2020 Oct;28(10):4585-4587. doi: 10.1007/s00520-020-05560-4. Epub 2020 Jun 9. Support Care Cancer. 2020. PMID: 32514617 Review.
An appraisal of emerging second line therapies for metastatic colorectal cancer.
Smolenschi C, Perret A, Dall'Armellina F, Boige V, Malka D, Hollebecque A, Ducreux M. Smolenschi C, et al. Among authors: perret a. Expert Rev Gastroenterol Hepatol. 2021 Feb;15(2):165-179. doi: 10.1080/17474124.2021.1840975. Epub 2020 Dec 13. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33085557
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study.
Gallois C, Hafliger E, Auclin E, Perret A, Coutzac C, Turpin A, Pellat A, Randrian V, Basile D, Faroux R, Pernot S, Locher C, Hautefeuille V, Dubreuil O, Palmieri LJ, Dior M, Artru P, Taieb J. Gallois C, et al. Among authors: perret a. Dig Liver Dis. 2022 May;54(5):684-691. doi: 10.1016/j.dld.2021.08.009. Epub 2021 Aug 29. Dig Liver Dis. 2022. PMID: 34470724
Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series.
Hafliger E, Boccaccino A, Lapeyre-Prost A, Perret A, Gallois C, Antista M, Pilla L, Lecomte T, Scartozzi M, Soularue E, Salvatore L, Bourgeois V, Salati M, Tougeron D, Evesque L, Vaillant JN, El-Khoury R, Lonardi S, Cremolini C, Taieb J. Hafliger E, et al. Among authors: perret a. Eur J Cancer. 2022 Jun;168:34-40. doi: 10.1016/j.ejca.2022.03.011. Epub 2022 Apr 15. Eur J Cancer. 2022. PMID: 35436675
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study.
Gallois C, Bergen ES, Auclin É, Pernot S, Higué J, Trouilloud I, Touchefeu Y, Turpin A, Mazard T, Sartore-Bianchi A, Prenen H, Alberti A, Pilla L, Cuissy S, Wookey V, Perret A, Melchior C, Artru P, Dubreuil O, Drouillard A, Doat S, Lavolé J, Basile D, Perkins G, Jary M, Stintzing S, Ros J, Tougeron D, Taieb J. Gallois C, et al. Among authors: perret a. ESMO Open. 2024 Sep;9(9):103696. doi: 10.1016/j.esmoop.2024.103696. Epub 2024 Sep 9. ESMO Open. 2024. PMID: 39255538 Free PMC article.
Colchicine is an active treatment for everolimus-induced oral ulcers.
Ropert S, Coriat R, Verret B, Perret A, Lucibello F, Chamseddine AN, Armand JP, Paci A, Mir O. Ropert S, et al. Among authors: perret a. Eur J Cancer. 2017 Dec;87:209-211. doi: 10.1016/j.ejca.2017.09.020. Epub 2017 Oct 13. Eur J Cancer. 2017. PMID: 29037756 No abstract available.
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.
Alouani E, Laparra A, Perret A, Sakkal M, Messayke S, Danlos FX, Ouali K, Hollebecque A, Even C, Ammari S, Baldini C, Champiat S, Besse B, Robert C, Guettier C, Samuel D, Lambotte O, De Martin E, Michot JM. Alouani E, et al. Among authors: perret a. Eur J Cancer. 2023 Nov;193:113313. doi: 10.1016/j.ejca.2023.113313. Epub 2023 Aug 26. Eur J Cancer. 2023. PMID: 37748398
110 results